MTC-DOX: Phase I/II data; Phase II/III

In a dose-escalating U.S. Phase I/II trial in which MTC-DOX was delivered to the tumor via selective hepatic arterial catheterization, 31 of 33 patients had tumor localization. FeRx also said measurem...